Sonoma Pharmaceuticals, Inc.
SNOA- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001367083
No open-market purchases or sales by Sonoma Pharmaceuticals, Inc. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $136.3K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −2 vs. previous quarter
- 14
- 13F valueReported value at the end of Q2 2026
- $136.3K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding SNOA, Q2 2026
No superinvestor reported holding SNOA at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Sonoma Pharmaceuticals, Inc. insiders from Form 4, newest first.
No open-market purchases or sales by Sonoma Pharmaceuticals, Inc. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Sonoma Pharmaceuticals, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 40,468 | $49.8K | 0.00% | +40,468 | New |
| Geode Capital Management, LLC | 26,787 | $32.9K | 0.00% | +6,846+34.3% | Added |
| Vanguard Capital Management LLC | 18,787 | $23.1K | 0.00% | 00.0% | Unchanged |
| McKinley Carter Wealth Services, Inc. | 11,193 | $13.8K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 7,808 | $9.60K | 0.00% | +7,802+130,033.3% | Added |
| Global Retirement Partners, LLC | 2,548 | $3.13K | 0.00% | +2,548 | New |
| Morgan Stanley | 2,000 | $2.46K | 0.00% | −4−0.2% | Reduced |
| Advisor Group Holdings, Inc. | 500 | $615 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 459 | $565 | 0.00% | +459 | New |
| BlackRock, Inc. | 113 | $139 | 0.00% | 00.0% | Unchanged |